Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematologic Diseases | 1 | 2022 | 11 | 0.780 |
Why?
|
| Students, Medical | 1 | 2022 | 96 | 0.710 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2018 | 26 | 0.600 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2019 | 17 | 0.310 |
Why?
|
| Sarcoma, Myeloid | 2 | 2019 | 7 | 0.310 |
Why?
|
| Mediastinal Neoplasms | 2 | 2018 | 11 | 0.290 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2018 | 16 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 464 | 0.240 |
Why?
|
| Laboratories | 1 | 2022 | 18 | 0.200 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2022 | 17 | 0.190 |
Why?
|
| Stomatitis, Aphthous | 1 | 2021 | 1 | 0.190 |
Why?
|
| Leukocyte Elastase | 1 | 2021 | 6 | 0.190 |
Why?
|
| Amyloidosis | 1 | 2021 | 9 | 0.190 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 9 | 0.190 |
Why?
|
| Neutropenia | 1 | 2021 | 41 | 0.180 |
Why?
|
| Humans | 13 | 2022 | 28121 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 82 | 0.170 |
Why?
|
| Mutation | 2 | 2021 | 848 | 0.170 |
Why?
|
| Chondromatosis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 4 | 0.170 |
Why?
|
| Curriculum | 1 | 2022 | 291 | 0.170 |
Why?
|
| Prognosis | 2 | 2021 | 803 | 0.170 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2020 | 20 | 0.170 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 37 | 0.160 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2019 | 4 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2019 | 8 | 0.160 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 14 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 22 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 21 | 0.160 |
Why?
|
| Gene Rearrangement | 1 | 2018 | 14 | 0.150 |
Why?
|
| Cytogenetic Analysis | 1 | 2018 | 10 | 0.150 |
Why?
|
| Clone Cells | 1 | 2018 | 22 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 31 | 0.150 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 8 | 0.150 |
Why?
|
| Lymphopoiesis | 1 | 2018 | 22 | 0.150 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 13 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 27 | 0.150 |
Why?
|
| Antibody-Producing Cells | 1 | 2018 | 15 | 0.150 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2018 | 16 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 44 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 477 | 0.150 |
Why?
|
| Placenta | 1 | 2018 | 75 | 0.150 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2018 | 12 | 0.140 |
Why?
|
| Platelet Count | 1 | 2018 | 111 | 0.140 |
Why?
|
| Salivary Glands | 1 | 2018 | 51 | 0.140 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 19 | 0.140 |
Why?
|
| Survival Rate | 1 | 2018 | 430 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 120 | 0.140 |
Why?
|
| Ploidies | 1 | 2017 | 6 | 0.140 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2017 | 3 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 37 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 109 | 0.140 |
Why?
|
| Prevalence | 1 | 2018 | 494 | 0.140 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 100 | 0.130 |
Why?
|
| Incidence | 1 | 2018 | 562 | 0.130 |
Why?
|
| Disease Progression | 1 | 2018 | 473 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 284 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 301 | 0.120 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 263 | 0.120 |
Why?
|
| Pregnancy | 1 | 2018 | 1181 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 678 | 0.100 |
Why?
|
| Female | 7 | 2021 | 15156 | 0.080 |
Why?
|
| Male | 6 | 2020 | 13487 | 0.070 |
Why?
|
| Adult | 4 | 2018 | 7757 | 0.060 |
Why?
|
| Middle Aged | 3 | 2019 | 7164 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2020 | 2380 | 0.050 |
Why?
|
| Adolescent | 2 | 2019 | 3123 | 0.040 |
Why?
|
| Chorionic Villi | 1 | 2018 | 7 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2019 | 42 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2018 | 15 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2018 | 14 | 0.040 |
Why?
|
| Capillaries | 1 | 2018 | 33 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2018 | 38 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 54 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 70 | 0.040 |
Why?
|
| Neck | 1 | 2018 | 26 | 0.040 |
Why?
|
| Dideoxynucleosides | 1 | 2017 | 12 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2018 | 118 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2017 | 136 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2018 | 118 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 103 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 98 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 71 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 208 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 323 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 411 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 451 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 432 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2242 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 804 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 825 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1249 | 0.030 |
Why?
|
| Aged | 1 | 2018 | 5416 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 10399 | 0.010 |
Why?
|